Supernus Pharmaceuticals (SUPN) Market Cap (2012 - 2026)
Supernus Pharmaceuticals (SUPN) market cap from May 1, 2012 to Jun 2, 2026. The current Supernus Pharmaceuticals (SUPN) market cap is $2.56B. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Market Cap
Supernus Pharmaceuticals (SUPN) Market Cap CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +43.90% |
| 3 Years TTM | +12.01% |
| 5 Years TTM | +14.63% |
| 10 Years TTM | +12.78% |
| All Time TTM | +19.19% |
Annual Market Cap change of Supernus Pharmaceuticals (SUPN)
| Year | Market Cap | Change |
|---|---|---|
| 2026 | $2.56B | -10.43% |
| 2025 | $2.86B | +41.67% |
| 2024 | $2.02B | +28.38% |
| 2023 | $1.57B | -17.35% |
| 2022 | $1.90B | +22.33% |
| 2021 | $1.55B | +16.75% |
| 2020 | $1.33B | +6.75% |
| 2019 | $1.25B | -28.30% |
| 2018 | $1.74B | -14.92% |
| 2017 | $2.04B | +63.31% |
| 2016 | $1.25B | +89.92% |
| 2015 | $659M | +84.65% |
| 2014 | $357M | +54.48% |
| 2013 | $231M | +5.16% |
| 2012 | $220M | N/A |
Comparison Supernus Pharmaceuticals (SUPN) market cap with competitors
Supernus Pharmaceuticals (SUPN) market cap is $2.56B.